MAPT and Alzheimer disease: P-tau phosphorylated at specific sites, such as threonine 181 (p-tau 181), serine 199 (p-tau 199), and serine 231 (p-tau 231), has shown greater specificity in distinguishing AD from other NDDs [129,131].